October 5, 2001
University Wins Battle for Rights to Promising Anti-Cancer Compound
The University of New Mexico at Albuquerque has prevailed in a lengthy court battle with two former researchers over who has clear title to potential cancer therapies that were developed at the institution.
The ruling last month by U.S. District Court Judge John Conway will allow Dovetail Technologies, a biotechnology company, to proceed with clinical trials of vitalethine, a chemical compound that has bolstered the ability of a mouse's immune system to fight cancer. The company
This is an article for subscribers only. You may access this article by purchasing a:
Digital or Print Subscription
Web Pass
Already have an account? Log In Now.
-
The Chronicle Review
-
Administration
-
Short Subjects
